Nascent Biotech Inc (NBIO)

Currency in USD
0.03
0.00(0.00%)
Delayed Data·
NBIO Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
NBIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.030.03
52 wk Range
0.010.10
Key Statistics
Prev. Close
-
Open
0.03
Day's Range
0.03-0.03
52 wk Range
0.01-0.1
Volume
-
Average Volume (3m)
15K
1-Year Change
-33.33%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NBIO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Nascent Biotech Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Nascent Biotech Inc Company Profile

Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. Nascent Biotech, Inc. is based in North Palm Beach, Florida.

Compare NBIO to Peers and Sector

Metrics to compare
NBIO
Peers
Sector
Relationship
P/E Ratio
0.0x−3.4x−0.5x
PEG Ratio
−0.10−0.010.00
Price/Book
−0.1x2.2x2.6x
Price / LTM Sales
-9.7x3.3x
Upside (Analyst Target)
-200.3%43.4%
Fair Value Upside
Unlock10.4%7.1%Unlock

Earnings

Latest Release
Aug 14, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

NBIO Income Statement

FAQ

What Stock Exchange Does Nascent Biotech Trade On?

Nascent Biotech is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Nascent Biotech?

The stock symbol for Nascent Biotech is "NBIO."

What Is the Nascent Biotech Market Cap?

As of today, Nascent Biotech market cap is 345.69K.

What Is Nascent Biotech's Earnings Per Share (TTM)?

The Nascent Biotech EPS (TTM) is -0.01.

From a Technical Analysis Perspective, Is NBIO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Nascent Biotech Stock Split?

Nascent Biotech has split 0 times.

How Many Employees Does Nascent Biotech Have?

Nascent Biotech has 0 employees.

What is the current trading status of Nascent Biotech (NBIO)?

As of 08 Aug 2025, Nascent Biotech (NBIO) is trading at a price of 0.03, with a previous close of 0.00. The stock has fluctuated within a day range of 0.03 to 0.03, while its 52-week range spans from 0.01 to 0.10.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.